NCT07389954

Brief Summary

Many patients report dreams during intravenous (IV) propofol sedation, but it is uncertain whether listening to music changes how often dreams occur or how pleasant they feel. This single-center randomized study compared three auditory conditions during propofol sedation for elective surgery under spinal anesthesia or peripheral nerve block: (1) patient-selected preferred music, (2) matched non-preferred music, and (3) silence (headphones only). Music or silence was delivered through identical closed-back headphones starting 1-2 minutes before sedation and continuing until the end of sedation. The main outcomes were (1) whether a dream occurred (yes/no) assessed by a neutral modified Brice interview in the post-anesthesia care unit (PACU), and (2) dream pleasantness rated on a 0-10 scale among participants who reported a dream. Additional outcomes included coded dream content features, patient satisfaction, sedative dose, hemodynamic variability, early recovery measures, postoperative symptoms, and adverse events.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 19, 2025

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 16, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 16, 2026

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

January 19, 2026

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 5, 2026

Completed
Last Updated

February 5, 2026

Status Verified

January 1, 2026

Enrollment Period

28 days

First QC Date

January 19, 2026

Last Update Submit

January 28, 2026

Conditions

Keywords

Procedural SedationIntravenous SedationPersonalized MusicPreferred MusicDream RecallDream Pleasantness

Outcome Measures

Primary Outcomes (2)

  • Dream Incidence (Yes/No) by Modified Brice Interview

    Dream occurrence (yes/no) assessed using a neutral modified Brice interview during early recovery in the PACU. Primary comparison: Music-pooled (Preferred or Non-preferred) vs Silence.

    PACU: primary at 15 minutes (±5) after arrival; if not ready, repeated every 5-10 minutes up to 60 minutes (first valid interview within 60 minutes).

  • Dream Pleasantness (0-10 Numeric Rating Scale) Among Recallers

    Dream pleasantness rated on a 0-10 Dream Pleasantness Numeric Rating Scale (minimum 0, maximum 10), where higher scores indicate more pleasant dreams (0 = not pleasant at all, 10 = extremely pleasant).

    Same PACU interview window as above: 15 minutes (±5) after PACU arrival; repeated every 5-10 minutes up to 60 minutes until readiness is met (first valid interview within 60 minutes).

Secondary Outcomes (14)

  • Dream Content Metrics (Blinded Coding) Among Recallers

    PACU interview window: first valid interview within 60 minutes after PACU arrival.

  • Patient Satisfaction (1-5 Scale)

    PACU (early recovery; within the PACU assessment period).

  • Intraoperative Mean Arterial Pressure Variability (Standard Deviation)

    During sedation (intraoperative period).

  • Intraoperative Heart Rate Variability (Standard Deviation)

    During sedation (intraoperative period).

  • Total Propofol Dose Administered

    During procedure and immediate recovery period.

  • +9 more secondary outcomes

Study Arms (3)

Preferred Music

EXPERIMENTAL

Participants listen to their self-selected preferred music through standardized closed-back headphones during intravenous propofol sedation. Music starts at the beginning of sedation and continues until the end of the procedure/recovery period per protocol.

Behavioral: Preferred Music

Matched Non-Preferred Music

EXPERIMENTAL

Participants listen to non-preferred music matched to the preferred-music selection (e.g., comparable tempo/energy/genre characteristics) through standardized closed-back headphones during intravenous propofol sedation. Playback timing and volume are standardized as in the preferred-music arm.

Behavioral: Matched Non-Preferred Music

Silence (Headphones Only)

PLACEBO COMPARATOR

Participants wear standardized closed-back headphones during intravenous propofol sedation, but no audio is played (silence condition). Procedures, timing, and staff interactions are otherwise identical to the music arms.

Behavioral: Silence (Headphones Only)

Interventions

Standardized closed-back headphones are used to deliver music during IV propofol sedation. Depending on randomization, participants receive e matched non-preferred music. Playback begins shortly before sedation and continues until the end of sedation; volume is calibrated per protocol.

Matched Non-Preferred Music

Participants wear identical closed-back headphones during IV propofol sedation, but no audio is played. Procedures, timing, and staff interactions are otherwise identical to the music arms.

Silence (Headphones Only)
Preferred MusicBEHAVIORAL

Standardized closed-back headphones are used to deliver music during IV propofol sedation. Depending on randomization, participants receive self-selected preferred music. Playback begins shortly before sedation and continues until the end of sedation; volume is calibrated per protocol.

Preferred Music

Eligibility Criteria

Age19 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged ≥ \[19\] years and ≤ \[70\] years.
  • Scheduled for an elective procedure under intravenous propofol sedation at Wonkwang University Hospital.
  • American Society of Anesthesiologists (ASA) physical status I-III.
  • Able to understand the study procedures and provide written informed consent.

You may not qualify if:

  • Known hearing impairment that would interfere with headphone-based auditory intervention.
  • Pre-existing cognitive impairment or delirium at baseline (e.g., diagnosed dementia or active delirium).
  • Use of sedatives, hypnotics, or psychoactive medications that could confound dreaming assessment, per protocol.
  • Significant neurologic or psychiatric disorder that may affect dream recall/reporting.
  • Inability to complete the postoperative PACU interview or inability to communicate reliably.
  • Any condition judged by the investigator to make participation unsafe or data uninterpretable.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRB of Wonkwnag University Hospital

Iksan, 54538, South Korea

Location

Study Officials

  • Cheol Lee, M.D.,Ph.D

    Department of anesthesiology and pain medicine, Wonkwang University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Allocation was concealed and managed by a non-assessor audio technician. Standardized closed-back headphones were used in all arms (silence arm without playback). PACU interviewers, content coders, and statisticians were blinded to group assignment; scripted interactions and volume calibration supported blinding.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Single-center, parallel-group, three-arm randomized controlled trial. Participants were allocated 1:1:1 to Preferred Music, Matched Non-preferred Music, or Silence (headphones without playback) during IV propofol sedation.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 19, 2026

First Posted

February 5, 2026

Study Start

December 19, 2025

Primary Completion

January 16, 2026

Study Completion

January 16, 2026

Last Updated

February 5, 2026

Record last verified: 2026-01

Locations